Found: 394
Select item for more details and to access through your institution.
Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02678-1
- By:
- Publication type:
- Article
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02667-4
- By:
- Publication type:
- Article
Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02666-5
- By:
- Publication type:
- Article
FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02659-4
- By:
- Publication type:
- Article
Phytogalactolipids activate humoral immunity against colorectal cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02660-x
- By:
- Publication type:
- Article
Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02665-6
- By:
- Publication type:
- Article
Retraction Note: Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02664-7
- By:
- Publication type:
- Article
COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02663-8
- By:
- Publication type:
- Article
LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02654-9
- By:
- Publication type:
- Article
Correction: Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
RETRACTED ARTICLE: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-022-02588-8
- By:
- Publication type:
- Article
Understanding the roles and regulation patterns of circRNA on its host gene in tumorigenesis and tumor progression.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02657-6
- By:
- Publication type:
- Article
Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02647-8
- By:
- Publication type:
- Article
Retraction Note: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02651-y
- By:
- Publication type:
- Article
Correction: CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Newly developed 3D in vitro models to study tumor–immune interaction.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02653-w
- By:
- Publication type:
- Article
Retraction Note: Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
FYN/TOPK/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02652-x
- By:
- Publication type:
- Article
Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02650-z
- By:
- Publication type:
- Article
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02640-1
- By:
- Publication type:
- Article
Methylglyoxal: a novel upstream regulator of DNA methylation.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02637-w
- By:
- Publication type:
- Article
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02640-1
- By:
- Publication type:
- Article
Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03016-9
- By:
- Publication type:
- Article
FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02630-3
- By:
- Publication type:
- Article
HES1-mediated down-regulation of miR-138 sustains NOTCH1 activation and promotes proliferation and invasion in renal cell carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02625-0
- By:
- Publication type:
- Article
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02633-0
- By:
- Publication type:
- Article
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02649-6
- By:
- Publication type:
- Article
PELI1: key players in the oncogenic characteristics of pancreatic Cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03008-9
- By:
- Publication type:
- Article
Correction: Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02641-0
- By:
- Publication type:
- Article
CLDN6 inhibits breast cancer metastasis through WIP-dependent actin cytoskeleton-mediated autophagy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02644-x
- By:
- Publication type:
- Article
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02628-x
- By:
- Publication type:
- Article
circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02642-z
- By:
- Publication type:
- Article
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02639-8
- By:
- Publication type:
- Article
METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02638-9
- By:
- Publication type:
- Article
CircFOXK2 promotes hepatocellular carcinoma progression and leads to a poor clinical prognosis via regulating the Warburg effect.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02624-1
- By:
- Publication type:
- Article
Research progress on non-protein-targeted drugs for cancer therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02635-y
- By:
- Publication type:
- Article
CD46 targeted <sup>212</sup>Pb alpha particle radioimmunotherapy for prostate cancer treatment.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02636-x
- By:
- Publication type:
- Article
Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02622-3
- By:
- Publication type:
- Article
Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02600-9
- By:
- Publication type:
- Article
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02634-z
- By:
- Publication type:
- Article
Retraction Note: Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02634-z
- By:
- Publication type:
- Article
Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02618-z
- By:
- Publication type:
- Article
NAD pool as an antitumor target against cancer stem cells in head and neck cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02631-2
- By:
- Publication type:
- Article
Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice